Delta 9 announces acquisition of Export License for Sale of Starting Materials to Australia, Provides update on International Activities
WINNIPEG, MB (May 8, 2019) – DELTA 9 CANNABIS INC. (TSXV: NINE) (OTCQX: VRNDF) (“Delta 9” or the “Company”) is pleased to provide investors with an update on the Company’s international activities.
On May 8, 2019, the Company received notice from Health Canada that it has been granted an export permit to sell starting materials to authorized cannabis license holders in Australia and Tasmania. The permit will allow the Company to complete orders for rooted cannabis plants for international sale.
“Delta 9 has two pending sales contracts for cannabis plants to licensed producers in Australia. The approval of the export license will mark Delta 9’s first international cannabis product sale this quarter”, said John Arbuthnot, CEO, “Our team has worked very hard to secure export permits and we continue to pursue international opportunities to bring Delta 9 products to global markets”
Delta 9 Grow Pods
The Company is reporting that it has also begun marketing and sales of its proprietary “Grow Pod” cultivation systems into the United States and completed its first shipment to a US operator this month.
The Company’s proprietary cannabis production methodology is based around a modular, scalable, and stackable production unit called a grow pod (a “Grow Pod”). The Company builds its Grow Pods by retrofitting standard shipping containers into Grow Pods. The Grow Pods are built to comply with Health Canada security requirements and good production practices and create optimal conditions for production of cannabis while effectively mitigating the risk of crop loss.
EU GMP Certification
The Company continues to pursue EU GMP certification for its Winnipeg based cultivation and processing facilities which will allow for export of medical cannabis flower and oil products into international markets. The Company anticipates receiving its certification within the calendar year 2019.
For more information contact:
Investor & Media Contact:
Ian Chadsey VP Corporate Affairs
About Delta 9 Cannabis Inc.
Delta 9 Cannabis is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical marijuana pursuant to the ACMPR and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9’s shares trade on the TSX Venture Exchange under the symbol “NINE” and on the OTC under the symbol VRNDF. For more information, please visit delta9.ca.,